Search

everythinglearnresearchcommunity

for

Search:↓

PHAT may improve hair growth better than PRP alone.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

The treatment using phenol and dexamethasone was effective for alopecia areata with no recurrence in 6 months.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Bicalutamide may help treat female pattern hair loss.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Finasteride doesn't raise acute pancreatitis risk.